Replies to post #27580 on BioCurex, Inc.(fka BOCX)

[opportunityknocking]

I know one person that is not a happy camper after that press release. LOL
So you can sleep tonite: BioCurex is a leading edge biotechnology company with proprietary and patented technologies in the areas of cancer diagnosis, imaging and therapy. The Company has developed a blood test that detects 90% of all cancers based on the cancer marker, RECAF™. The RECAF test has a high sensitivity and specificity for breast and lung cancers, which are two of the most common and deadly cancers. There are no comparable cancer markers available for detection of early stages of breast and prostate cancer. BioCurex has indicated that RECAF detects cancer with higher sensitivity/specificity than
mammograms or colonoscopies.
Time to go fishing. Play nice!

[Gold Seeker]

Opportunity, the guy running the two hedge fund lending Moro money is Richard Smithline, so you can stop using the term "they".

Now, Smithline is still highly connected with this stock. The company still owes him about $600,000 and he had 3.5 million warrants at 13.5 cents. Why would he ever sell those warrants if he thought the warrants might have some value someday. He no doubt sold them for about a penny each. That sure doesn't give you much confidence in the stock going up in the near future.

Smithline still has a lien on all the assets and the patents are in his name.